Clinical dosimetry study of kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T

被引：0
|
作者：
Uijen, M. [1 ]
Prive, B. [1 ]
van Herpen, C. [1 ]
Gotthardt, M. [1 ]
Konijnenberg, M. [1 ]
Peters, S. [1 ]
Nagarajah, J. [1 ]
机构：
[1] Radboudumc, Nijmegen, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0284
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 50 条
  • [31] Molecular imaging and biochemical response assessment after a single cycle of [225Ac]Ac-PSMA-617/[177Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [177Lu]Lu-PSMA-617 monotherapy
    Rosar, Florian
    Hau, Fabian
    Bartholoma, Mark
    Maus, Stephan
    Stemler, Tobias
    Linxweiler, Johannes
    Ezziddin, Samer
    Khreish, Fadi
    [J]. THERANOSTICS, 2021, 11 (09): : 4050 - 4060
  • [32] Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617
    Martin, Sebastian
    Tonnesmann, Roswitha
    Hierlmeier, Ina
    Maus, Stephan
    Rosar, Florian
    Ruf, Juri
    Holland, Jason P.
    Ezziddin, Samer
    Bartholoma, Mark D.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (08) : 4960 - 4971
  • [33] Castration-resistant prostate cancer: [177Lu]Lu-PSMA-617 versus cabazitaxel Comment
    Todenhoefer, Tilman
    [J]. AKTUELLE UROLOGIE, 2023, 54 (04)
  • [34] Combining enzalutamide and [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
    Houede, Nadine
    Hebert, Kevin
    [J]. LANCET ONCOLOGY, 2024, 25 (05): : 531 - 533
  • [35] Improved quality control of [177Lu]Lu-PSMA I&T
    Kraihammer, Martin
    Garnuszek, Piotr
    Bauman, Andreas
    Maurin, Michael
    Lafont, Manuel Alejandre
    Haubner, Roland
    von Guggenberg, Elisabeth
    Gabriel, Michael
    Decristoforo, Clemens
    [J]. EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [36] Improved quality control of [177Lu]Lu-PSMA I&T
    Martin Kraihammer
    Piotr Garnuszek
    Andreas Bauman
    Michael Maurin
    Manuel Alejandre Lafont
    Roland Haubner
    Elisabeth von Guggenberg
    Michael Gabriel
    Clemens Decristoforo
    [J]. EJNMMI Radiopharmacy and Chemistry, 8
  • [37] Clinical dosimetry in [177Lu]Lu-PSMA therapy: kidney mean absorbed dose difference between subsequent cycles
    Owers, E.
    Rijkhorst, E.
    Dotinga, M.
    de Wit-van der Veen, L. J.
    de Vries-Huizing, D. M. V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S368 - S368
  • [38] Re-challenge [177Lu]Lu-PSMA-617 in patients with advanced prostate cancer: outcome and safety
    Yordanova, Anna
    Essler, Markus
    Hauser, Stefan
    Feldmann, Georg
    Ahmadzadehfar, Hojjat
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [39] Discovery of Glutamate Carboxypeptidase III Ligands to Compete the Uptake of [177Lu]Lu-PSMA-617 in Healthy Organs
    Mueller, Marco
    Lucaroni, Laura
    Favalli, Nicholas
    Bassi, Gabriele
    Neri, Dario
    Cazzamalli, Samuele
    Oehler, Sebastian
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (10) : 8247 - 8260
  • [40] Characterization of Non-Specific Uptake and Retention Mechanisms of [177Lu]Lu-PSMA-617 in the Salivary Glands
    Heynickx, Nathalie
    Segers, Charlotte
    Coolkens, Amelie
    Baatout, Sarah
    Vermeulen, Koen
    [J]. PHARMACEUTICALS, 2023, 16 (05)
12345